Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 28:11:602823.
doi: 10.3389/fimmu.2020.602823. eCollection 2020.

CD8+ T Lymphocytes: Crucial Players in Sjögren's Syndrome

Affiliations
Review

CD8+ T Lymphocytes: Crucial Players in Sjögren's Syndrome

Huimin Zhou et al. Front Immunol. .

Abstract

Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease associated with damage to multiple organs and glands. The most common clinical manifestations are dry eyes, dry mouth, and enlarged salivary glands. Currently, CD4+ T lymphocytes are considered to be key factors in the immunopathogenesis of pSS, but various studies have shown that CD8+ T lymphocytes contribute to acinar injury in the exocrine glands. Therefore, in this review, we discussed the classification and features of CD8+ T lymphocytes, specifically describing the role of CD8+ T lymphocytes in disease pathophysiology. Furthermore, we presented treatment strategies targeting CD8+ T cells to capitalize on the pathogenic and regulatory potential of CD8+ T lymphocytes in SS to provide promising new strategies for this inflammatory disease.

Keywords: CD8+ T lymphocyte; Sjögren’s syndrome; immune regulation; pathophysiology; tissue resident lymphocyte.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Activated CD8+T cells are involved in the mechanism of salivary gland injury. The upper part of the panel shows naïve CD8+ T differentiated into subgroups. CTLs and memory CD8+ T cells play important roles in the organization. The lower part of the panel highlights the tissues damage caused by activated CD8+ T entering the salivary glands. Pathological examination of apoptotic acinar cells in the salivary glands and lacrimal glands of patients with SS revealed the accumulation of CD8+ T cells and fewer CD4+ T cells expressing integrin αEβ7 (CD103) (12). A kind of cytotoxic memory T cell called CD8+ TRM cells and CTLs producing GrB/perforin can induce acinar cells death (53, 72). CTLs recognize pMHCI presented by the acinar cells, then specific T cell receptor (TCR) and co-receptors to contact parts, promoting the secretion of such as IFN-γ, TNF-α, GrB/perforin. In addition, CTLs can express FasL or secrete TNF-α, which bind to Fas and TNF receptors (TNFR) on the surface of acinar cells respectively and induce apoptosis mediated by caspase signaling pathways (73, 74). There are also a large number of inflammatory cells such as CD4+T cells and B cells in the glandular tissue, which cooperate with CD8+T cells to play an immune effect and cause tissues damage. Treg *: CXCR5+Foxp3+/−CD8+Treg; Tfc *: CXCR5+PD-1int-CD8+Tfc; Tfh *: CXCR5+PD-1highCD8+Tfh.

Similar articles

Cited by

References

    1. Brito-Zeron P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, et al. Sjogren syndrome. Nat Rev Dis Primers (2016) 2:16047. 10.1038/nrdp.2016.47 - DOI - PubMed
    1. Mavragani CP. Mechanisms and New Strategies for Primary Sjogren’s Syndrome. Annu Rev Med (2017) 68:331–43. 10.1146/annurev-med-043015-123313 - DOI - PubMed
    1. Nocturne G, Mariette X. B cells in the pathogenesis of primary Sjogren syndrome. Nat Rev Rheumatol (2018) 14(3):133–45. 10.1038/nrrheum.2018.1 - DOI - PubMed
    1. Baldini C, Ferro F, Elefante E, Bombardieri S. Biomarkers for Sjögren’s syndrome. Biomark Med (2018) 12(3):275–86. 10.2217/bmm-2017-0297 - DOI - PubMed
    1. Farhood B, Najafi M, Mortezaee K. CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: A review. J Cell Physiol (2019) 234(6):8509–21. 10.1002/jcp.27782 - DOI - PubMed

Publication types

MeSH terms

Substances